Abstract
The association of low doses of interleukin-2 (IL-2; 5 IU/ml) and interferon beta (IFN beta; 10 IU/ml) induced an additive or synergic stimulatory effect on natural killer (NK) activity (32%) in peripheral blood samples from hairy-cell leukemia patients, both those with active disease and those in remission. The synergic NK stimulatory effect was more commonly found in samples from patients with active disease, while the additive effect was more frequent in the patients in remission. The IL-2/IFN beta combination provoked a nonadditive nonsynergic NK-stimulatory effect in a further 19.8% samples. The targets of the IL-2/IFN beta combination were typical NK cells, as shown by the fact that there was increased cytotoxicity (synergic, additive or nonadditive nonsynergic) against the K562, but not the Daudi cell line in peripheral blood mononuclear cell samples treated with the combination of the two cytokines. When CD16+/CD56+ or CD57+/CD16+/CD56+ cells were removed, the NK-stimulatory effect was lost. The fact that the NK-cell-enhancing activity of the IL-2/IFN beta combination was reduced when Percoll fractions 2 and 3 were used, but still persisted in 66% of tests, may have been due to cytotoxicity being higher in the untreated...Continue Reading
References
Aug 1, 1991·Clinical and Experimental Immunology·R K Puri, P Leland
Jan 1, 1991·Cancer Immunology, Immunotherapy : CII·A M LiberatiL Palmisano
Sep 1, 1990·Blood Reviews·S L Zaknoen, N E Kay
Jan 1, 1989·Cancer Immunology, Immunotherapy : CII·T J EberleinD D Schoof
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A AllisonP McGuffey
Jan 1, 1989·European Journal of Haematology·B NielsenP Hokland
Jun 1, 1987·Cancer·A M LiberatiL Cini
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A ThompsonA Fefer
Apr 9, 1987·The New England Journal of Medicine·J R Durant
Jan 1, 1987·Leukemia Research·L TrentinG Semenzato
Mar 1, 1981·The Journal of Experimental Medicine·T TimonenR B Herberman
Mar 15, 1981·International Journal of Cancer. Journal International Du Cancer·H W ZieglerJ M Zarling
May 1, 1980·British Journal of Haematology·F R DaveyJ A Wolos
Jan 1, 1981·Advances in Cancer Research·M C Berenbaum